CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $621 | -58.4% | 13,676 | -48.6% | 0.06% | -45.6% |
| Q2 2023 | $1,492 | -99.8% | 26,583 | +93.0% | 0.11% | +39.0% |
| Q3 2022 | $900,000 | -73.7% | 13,777 | -75.5% | 0.08% | -71.8% |
| Q2 2022 | $3,422,000 | +143.4% | 56,311 | +151.4% | 0.29% | +179.8% |
| Q1 2022 | $1,406,000 | +70.6% | 22,401 | +106.0% | 0.10% | +23.8% |
| Q4 2021 | $824,000 | -67.8% | 10,876 | -48.2% | 0.08% | -53.6% |
| Q1 2021 | $2,559,000 | +944.5% | 21,000 | +292.4% | 0.18% | +1292.3% |
| Q1 2018 | $245,000 | – | 5,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |